Zobrazeno 1 - 10
of 30
pro vyhledávání: '"H J, Pielken"'
Autor:
Bernhard Wörmann, Maria-Cristina Sauerland, Detlef Haase, Peter Staib, T. Haferlach, H. E. Reis, Achim Heinecke, T. Büchner, Wolfgang Hiddemann, Wolf-Dietrich Hirschmann, W.-D. Ludwig, Wolfgang E. Berdel, Joachim Hartlapp, Hartmut Eimermacher, Winfried Gassmann, Herbert Rasche, Georg Maschmeyer, Andreas Grüneisen, C. Aul, Jens Uhlig, Helmut Löffler, Leopold Balleisen, Claudia Schoch, Reinhard Andreesen, Hans-Josef Weh, H. J. Pielken
Publikováno v:
Cancer Chemotherapy and Pharmacology. 48:S41-S44
Intensive induction therapy in acute myeloid leukemia (AML) as in some other systemic malignancies is a strategy fundamentally different from post-remission strategies. Approaches such as consolidation treatment, prolonged maintenance, and autologous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1b7dc9b11cdd444b2f2797947adb76
https://doi.org/10.1007/s002800100305
https://doi.org/10.1007/s002800100305
Autor:
Lothar Bergmann, Dieter Hoelzer, U. Reinhardt, K. Josten, Alexander Knuth, Eva Lengfelder, M. Schenk, C. Renner, H.-J. Pielken, Mathias J. Rummel, B. Rendenbach, Paris S. Mitrou, C. Wojatschek
Publikováno v:
Oncology Research and Treatment. 20:328-331
Background: Fludarabine has been reported to be the most effective single agent in previously treated chronic lymphocytic leukemia (CLL). Based on in vitro synergism of fludarabine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bb6800b33905253ef9e8d5529461b26
https://doi.org/10.1159/000218964
https://doi.org/10.1159/000218964
Autor:
C. Aul, Helmut Löffler, Hartmut Eimermacher, A. Giagounidis, Eva Lengfelder, Bernhard Wörmann, H. E. Reis, Achim Heinecke, Peter Staib, Wolfgang Hiddemann, Georg Maschmeyer, F. Griesinger, Leopold Balleisen, G. Schott, A. Reichle, Maria-Cristina Sauerland, Wolfgang E. Berdel, T. Haferlach, A. Heyll, H. J. Pielken, T. Büchner, Claudia Schoch, Andreas Grüneisen, W.-D. Ludwig, Herbert Rasche
Publikováno v:
Haematology and Blood Transfusion Hämatologie und Bluttransfusion ISBN: 9783642639494
The outcome in patients with AML appears influenced by some therapeutic variables such as different intensity chemotherapy, growth factor priming, autologous or allogeneic transplantation. Even more than by treatment variables the outcome is determin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e990a6198b9f5ef83558e66775e9b30
https://doi.org/10.1007/978-3-642-59358-1_62
https://doi.org/10.1007/978-3-642-59358-1_62
Autor:
T, Büchner, W, Hiddemann, B, Wörmann, H, Löffler, W D, Ludwig, C, Schoch, T, Haferlach, G, Maschmeyer, P, Staib, C, Aul, G A, Heyll, A, Grüneisen, H, Rasche, J H, Eimermacher, L, Balleisen, H J, Pielken, H E, Reis, F, Griesinger, A, Reichle, M C, Sauerland, A, Heinecke
Publikováno v:
International journal of hematology. 72(3)
Maintenance treatment for patients with acute myeloid leukemia (AML) in remission has recently been controversially discussed and even abandoned by several groups. An analysis of 14 recently published multicenter trials, however, revealed the highest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9ade80188163683a6b2915971b2ee43
https://pubmed.ncbi.nlm.nih.gov/11185983
https://pubmed.ncbi.nlm.nih.gov/11185983
Autor:
R, Becher, O, Kloke, J, Hayungs, G, Hartwich, H, Bartels, J, Szanto, E, Wolf, H J, Illiger, S, Halabi, K, Rieche, K G, Hering, S, Ohl, R, DeDycker, R, Huhn, A R, Fischedick, H, Höfeler, H J, Pielken, I, Hawig, H, Hirche, S, Seeber
Publikováno v:
Seminars in oncology. 23(3 Suppl 7)
In a randomized, phase II trial, we evaluated the effectiveness of continued chemotherapy with epirubicin/ ifosfamide versus unmaintained treatment interruption in advanced metastatic breast cancer. Three hundred fifty-seven patients were enrolled an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4e5b013fe541cf5c12717b39f00c7018
https://pubmed.ncbi.nlm.nih.gov/8711499
https://pubmed.ncbi.nlm.nih.gov/8711499
Autor:
H. Hirche, A.R. Fischedick, Susan Halabi, I. Hawig, S. Öhl, J. Urban, H.-J. Pielken, Becher R, K.G. Hering, J. Hayungs, H. Bartels, K. Rieche, János Szántó, H. Höfeler, G. Hartwich, R. P. De Dycker, S. Huhn, S. Seeber, C. Bechtel, E. Wolf, G. Abelein
Publikováno v:
The Breast. 2:194-195
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c7a9dc7f77e79188e1492731a71f1e0
https://doi.org/10.1016/0960-9776(93)90104-n
https://doi.org/10.1016/0960-9776(93)90104-n
Autor:
M. Walter, H. H. Fülle, Ch. Anders, G. Middelhoff, P. Koch, D. K. Hossfeld, A. D. Ho, H. Rühl, G. Zeile, W. Augener, F. Wendt, P. Meusers, Winfried Gassmann, L. Demling, Hubert Köppler, Carlo Aul, J. Schwamborn, A. Mohr, H.J. König, Wolfgang Siegert, K.-P. Hellriegel, H.W. Pees, Georg Maschmeyer, R. Kuse, Friedrich Overkamp, M. R. Nowrousian, Helmut Löffler, K.-H. Zurborn, J.T. Fischer, D. Urbanitz, Wolfgang Hiddemann, M. Planker, Eva Lengfelder, T. Büchner, Bertold Emmerich, Eckhard Thiel, H. Bartels, H.A. Vaupel, W. Schneider, Achim Heinecke, K. Mainzer, A. Von Paleske, R. Donhuijsen-Ant, H. Seibt, K. Straif, W.-D. Ludwig, B. Bonfert, H. Kreutzmann, H. J. Pielken, L. Nowicki
Publikováno v:
Oncology Research and Treatment. 9:83-91
Ein Uberblick einschlagiger Therapiestudien bei AML des Erwachsenen zeigt keine durchbruchartigen, wegweisenden Therapiefortschritte in den 80er Jahren. Diese liegen bereits in den 70er Jahren, etwa bei einigen wirksamen Induktionsregimen. Fortschrit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9902791b2c88688d9351ed5d770d6579
https://doi.org/10.1159/000215970
https://doi.org/10.1159/000215970
Autor:
Georg Maschmeyer, W.-D. Ludwig, H. Rühl, Ch. Anders, F. Wendt, Bertold Emmerich, M. Planker, D. Urbanitz, Helmut Löffler, W. Schneider, H. Bartels, A. Mohr, H.J. König, J.T. Fischer, H.A. Vaupel, A. D. Ho, R. Kuse, W. Augener, Roland Mertelsmann, Hubert Köppler, Winfried Gassmann, H. Seibt, J. Schwamborn, K. Straif, P. Koch, Wolfgang Siegert, K.-P. Hellriegel, P. Meusers, M. R. Nowrousian, H. Kreutzmann, Achim Heinecke, L. Demling, T. Büchner, M. Walter, Carlo Aul, Eckhard Thiel, G. Middelhoff, H. H. Fülle, K.-H. Zurborn, D. K. Hossfeld, Eva Lengfelder, L. Nowicki, A. Von Paleske, K. Mainzer, H.W. Pees, Friedrich Overkamp, R. Donhuijsen-Ant, B. Bonfert, H. J. Pielken, Wolfgang Hiddemann
Publikováno v:
Oncology Research and Treatment. 10:14-16
Die randomisierte, multizentrische bundesdeutsche Studie 1982 zeigt nach TAD9-Induktion und Konsolidierung einen klaren, signifikanten Vorteil der Remissionsdauer und weniger ausgepragt auch des Uberl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aca3f5f1fe516b95c584b417173b0d04
https://doi.org/10.1159/000216360
https://doi.org/10.1159/000216360
Autor:
T. Büchner, P. Koch, G. Maschmeier, H. J. Pielken, Achim Heinecke, J. van de Loo, Wolfgang Hiddemann, D. Urbanitz, F. Wendt
Publikováno v:
Oncology Research and Treatment. 8:157-159
102 patients with AML (leukemia after preleukemia, 2nd neoplasia included) were treated for remission induction by a modified TAD regimen in Munster; 55 patients (54%) achieved a complete remission (CR). For CR maintenance 40 patients were eligible f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::971534621f269fe4da0b82b61a282507
https://doi.org/10.1159/000215644
https://doi.org/10.1159/000215644
Autor:
D, Urbanitz, H J, Pielken, P, Koch, T, Büchner, W, Hiddemann, A, Heinecke, F, Wendt, G, Maschmeier, J, van de Loo
Publikováno v:
Onkologie. 8(3)
102 patients with AML (leukemia after preleukemia, 2nd neoplasia included) were treated for remission induction by a modified TAD regimen in Munster; 55 patients (54%) achieved a complete remission (CR). For CR maintenance 40 patients were eligible f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::63b467c7c9453ccbeaedf7ee080e86ec
https://pubmed.ncbi.nlm.nih.gov/3895098
https://pubmed.ncbi.nlm.nih.gov/3895098